JP2832979B2
(ja)
*
|
1988-02-15 |
1998-12-09 |
武田薬品工業株式会社 |
不飽和カルボン酸アミド誘導体
|
HU207310B
(en)
*
|
1988-12-02 |
1993-03-29 |
Pfizer |
Process for producing aryl-piperidine derivatives
|
JP2777159B2
(ja)
|
1988-12-22 |
1998-07-16 |
エーザイ株式会社 |
環状アミン誘導体を含有する医薬
|
JP2969359B2
(ja)
*
|
1989-01-13 |
1999-11-02 |
武田薬品工業株式会社 |
環状アミン化合物
|
US5225402A
(en)
*
|
1989-02-10 |
1993-07-06 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives
|
JP2931986B2
(ja)
*
|
1989-02-17 |
1999-08-09 |
武田薬品工業株式会社 |
アラルキルアミン誘導体
|
US5250528A
(en)
*
|
1989-08-02 |
1993-10-05 |
Fujisawa Pharmaceutical Co., Ltd. |
New aminopiperazine derivatives
|
US5109002A
(en)
*
|
1989-09-08 |
1992-04-28 |
Du Pont Merck Pharmaceutical Company |
Antipsychotic 1-cycloalkylpiperidines
|
US5356906A
(en)
*
|
1989-10-27 |
1994-10-18 |
The Du Pont Merck Pharmaceutical Company |
(N-phthalimidoalkyl) piperidines useful as treatments for psychosis
|
EP0497843A4
(en)
*
|
1989-10-27 |
1992-09-23 |
The Du Pont Merck Pharmaceutical Company |
(n-phthalimidoalkyl) piperidines
|
HUT55358A
(en)
*
|
1989-10-30 |
1991-05-28 |
Syntex Inc |
Process for producing benzylpyrrolidine derivatives with dopamin antagonist effect and pharmaceutical compositions comprising such compounds
|
US5112824A
(en)
*
|
1989-12-08 |
1992-05-12 |
Merck & Co., Inc. |
Benzofuran compounds as class III antiarrhythmic agents
|
US5206240A
(en)
*
|
1989-12-08 |
1993-04-27 |
Merck & Co., Inc. |
Nitrogen-containing spirocycles
|
US5032598A
(en)
*
|
1989-12-08 |
1991-07-16 |
Merck & Co., Inc. |
Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
|
US5032604A
(en)
*
|
1989-12-08 |
1991-07-16 |
Merck & Co., Inc. |
Class III antiarrhythmic agents
|
US5215989A
(en)
*
|
1989-12-08 |
1993-06-01 |
Merck & Co., Inc. |
Nitrogen-containing heterocyclic compounds as class III antiarrhythmic agents
|
EP0507863A4
(en)
*
|
1989-12-28 |
1993-07-07 |
Virginia Commonwealth University |
Sigma receptor ligands and the use thereof
|
US5428043A
(en)
*
|
1990-02-08 |
1995-06-27 |
Pfizer Inc. |
Tricyclic-cyclic amines as novel cholinesterase inhibitors
|
FR2659323B1
(fr)
*
|
1990-03-07 |
1992-06-12 |
Synthelabo |
Derives de 4-(aminomethyl) piperidine, leur preparation et leur application en therapeutique.
|
US5272157A
(en)
*
|
1990-03-07 |
1993-12-21 |
Synthelabo |
Derivatives of 4-(aminomethyl) piperidine, their preparation and their therapeutic application
|
US5116846A
(en)
*
|
1990-03-28 |
1992-05-26 |
Du Pont Merck Pharmaceutical Company |
N-aralkyl piperidine derivatives as psychotropic drugs
|
US5173209A
(en)
*
|
1990-05-10 |
1992-12-22 |
Cyprus Foote Mineral Company |
Stable lithium cycloalkylimides
|
US6004980A
(en)
*
|
1990-06-01 |
1999-12-21 |
Merrell Pharmaceuticals, Inc. |
(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
|
CA2083698C
(en)
*
|
1990-06-01 |
1997-11-04 |
Albert A. Carr |
(+)-alpha-(2,3-dimethoxyphenyl)-1- [2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
|
JP2807577B2
(ja)
*
|
1990-06-15 |
1998-10-08 |
エーザイ株式会社 |
環状アミド誘導体
|
DE69123090D1
(de)
*
|
1990-07-06 |
1996-12-19 |
Yoshitomi Pharmaceutical |
Kondensierte Thiophenverbindungen und deren Verwendung
|
FR2664592B1
(fr)
*
|
1990-07-10 |
1994-09-02 |
Adir |
Nouveaux derives de la piperidine, de la tetrahydropyridine et de la pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
TW199153B
(fi)
*
|
1990-08-07 |
1993-02-01 |
Dtsuka Seiyaku Kk |
|
US5190951A
(en)
*
|
1990-10-19 |
1993-03-02 |
Ss Pharmaceutical Co., Ltd. |
Quinoline derivatives
|
US5240934A
(en)
*
|
1990-10-19 |
1993-08-31 |
Ss Pharmaceutical Co., Ltd. |
Quinoline derivatives
|
TW197435B
(fi)
*
|
1990-11-22 |
1993-01-01 |
Takeda Pharm Industry Co Ltd |
|
DE4104870A1
(de)
*
|
1991-02-17 |
1992-08-27 |
Bayer Ag |
Verwendung von 3,(4)-substituierten pyrrolidinen als katalysatoren fuer das polyisocyanatpolyadditionsverfahren, verfahren zu ihrer herstellung sowie verfahren zur herstellung von polyurethan(harnstoff)en
|
US5162341A
(en)
*
|
1991-02-22 |
1992-11-10 |
Du Pont Merck Pharmaceutical Company |
Use of sigma receptor antagonists for treatment of amphetamine abuse
|
US5750542A
(en)
|
1993-09-28 |
1998-05-12 |
Pfizer |
Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors
|
RU2119920C1
(ru)
*
|
1991-03-28 |
1998-10-10 |
Эйсай Ко., Лтд. |
Гетероцикло-циклические производные аминов или их фармацевтически приемлемые соли, промежуточные соединения, фармацевтическая композиция, способ ингибирования холинэстеразы, способ получения соединений
|
FR2676225B1
(fr)
*
|
1991-05-03 |
1993-08-27 |
Sanofi Elf |
Nouveaux intermediaires pour la synthese de composes dialkylenepiperidino.
|
FR2676226B1
(fr)
*
|
1991-05-03 |
1993-08-27 |
Sanofi Elf |
Nouveaux intermediaires pour la synthese de composes dialkylenepiperidino.
|
CA2067475C
(en)
*
|
1991-05-08 |
2000-10-10 |
Yasuo Oshiro |
Carbostyril derivatives and their use
|
US5556857A
(en)
*
|
1991-05-08 |
1996-09-17 |
Otsuka Pharmaceutical Co., Ltd. |
Disturbance-of-consciousness improving agent
|
FR2677019B1
(fr)
*
|
1991-05-27 |
1994-11-25 |
Pf Medicament |
Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
|
US5106856A
(en)
*
|
1991-06-07 |
1992-04-21 |
Hoechst-Roussel Pharmaceuticals Inc. |
[(Arylalkylpiperidin-4-yl)methyl]-2a,3,4,5-tetrahydro-1(2H)-acenaphthylen-1-ones and related compounds
|
EP0535496A1
(en)
|
1991-09-25 |
1993-04-07 |
Hoechst-Roussel Pharmaceuticals Incorporated |
(1-Indanon-2yl)methylpiperidines, intermediates and a process for their preparation and their use as medicaments
|
TW263504B
(fi)
*
|
1991-10-03 |
1995-11-21 |
Pfizer |
|
SE9103752D0
(sv)
*
|
1991-12-18 |
1991-12-18 |
Astra Ab |
New compounds
|
US5462934A
(en)
*
|
1992-03-09 |
1995-10-31 |
Takeda Chemical Industries |
Condensed heterocyclic ketone derivatives and their use
|
EP0567090B1
(en)
|
1992-04-24 |
2000-07-26 |
Takeda Chemical Industries, Ltd. |
Benzoxazepine derivatives as cholinesterase inhibitors
|
KR100262254B1
(ko)
*
|
1992-10-05 |
2000-07-15 |
나카히로 마오미 |
피리미딘 화합물
|
US5948793A
(en)
*
|
1992-10-09 |
1999-09-07 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release
|
US5914328A
(en)
*
|
1992-10-09 |
1999-06-22 |
Abbott Laboratories |
Heterocyclic ether compounds useful in controlling neurotransmitter release
|
TW248556B
(fi)
*
|
1993-01-18 |
1995-06-01 |
Takeda Pharm Industry Co |
|
US5656642A
(en)
*
|
1993-04-07 |
1997-08-12 |
Otsuka Pharmaceutical Co., Ltd. |
Peripheral vasodilating agent containing piperidine derivative as active ingredient
|
US5459151A
(en)
*
|
1993-04-30 |
1995-10-17 |
American Home Products Corporation |
N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
|
CA2166100A1
(en)
*
|
1993-06-23 |
1995-01-05 |
Richard A. Glennon |
Sigma receptor ligands and the use thereof
|
ATE180780T1
(de)
*
|
1993-08-05 |
1999-06-15 |
Hoechst Marion Roussel Inc |
2-(piperidin-4-yl, pyridin-4-yl und tetrahydropyridin-4-yl)-benzofuran-7-carbamat derivate, ihre herstellung und verwendung als acetylcholinesterase inhibitoren
|
GB9319534D0
(en)
*
|
1993-09-22 |
1993-11-10 |
Boots Co Plc |
Therapeutic agents
|
ATE159706T1
(de)
*
|
1993-11-30 |
1997-11-15 |
Pfizer |
Verfahren zur herstellung von chiralen tetralonen
|
DE4439822A1
(de)
*
|
1994-11-08 |
1996-08-29 |
Bayer Ag |
Verfahren zur Herstellung von Benzyl-piperidylmethyl-indanonen
|
US5658909A
(en)
*
|
1994-11-17 |
1997-08-19 |
Molecular Geriatrics Corporation |
Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's Disease
|
US6214994B1
(en)
|
1997-04-21 |
2001-04-10 |
Molecular Geriatrics Corporation |
Certain substituted 1-aryl-3-piperazin-1′-yl propanones
|
US5859295A
(en)
*
|
1994-12-05 |
1999-01-12 |
University Of Kentucky Research Foundation |
Canavanine analogs and their use as chemotherapeutic agents
|
AU4483896A
(en)
*
|
1995-01-18 |
1996-08-07 |
Bayer Aktiengesellschaft |
N-substituted 1-acylaminoalkyl piperidines for treatment of cerebral disorders and depressions
|
IL117149A0
(en)
|
1995-02-23 |
1996-06-18 |
Schering Corp |
Muscarinic antagonists
|
US5889006A
(en)
*
|
1995-02-23 |
1999-03-30 |
Schering Corporation |
Muscarinic antagonists
|
US5703239A
(en)
*
|
1995-06-02 |
1997-12-30 |
Bristol-Myers Squibb Company |
Indanylpiperidines as melatonergic agents
|
US20100210590A1
(en)
*
|
1995-09-27 |
2010-08-19 |
Northwestern University |
Compositions and treatments for seizure-related disorders
|
HUP9904275A3
(en)
*
|
1995-12-15 |
2001-05-28 |
Pfizer |
Processes and intermediates for preparing 1-benzyl-4-(5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine
|
US6025355A
(en)
|
1997-05-19 |
2000-02-15 |
Cambridge Neuroscience, Inc. |
Pharmaceutically active compounds and methods of use
|
US6437138B1
(en)
|
1996-06-06 |
2002-08-20 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
US5629325A
(en)
*
|
1996-06-06 |
1997-05-13 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
TW513409B
(en)
*
|
1996-06-07 |
2002-12-11 |
Eisai Co Ltd |
Polymorphs of donepezil hydrochloride
|
AU731282B2
(en)
*
|
1996-06-07 |
2001-03-29 |
Eisai Co. Ltd. |
Polymorphs of donepezil hydrochloride and process for production
|
WO1997046526A1
(en)
*
|
1996-06-07 |
1997-12-11 |
Eisai Co., Ltd. |
Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
|
US5935958A
(en)
*
|
1996-07-01 |
1999-08-10 |
Schering Corporation |
Muscarinic antagonists
|
FR2750991A1
(fr)
*
|
1996-07-12 |
1998-01-16 |
Pf Medicament |
Nouveaux benzodioxannes et 1-(2h)-benzopyrannes, leur preparation et leur utilisation comme medicament
|
US6242198B1
(en)
|
1996-07-25 |
2001-06-05 |
Cambridge Neuroscience, Inc. |
Methods of treatment of eye trauma and disorders
|
US6756389B2
(en)
|
1996-08-09 |
2004-06-29 |
Cambridge Neuroscience, Inc. |
Pharmaceutically active compounds and methods of use
|
US5977138A
(en)
*
|
1996-08-15 |
1999-11-02 |
Schering Corporation |
Ether muscarinic antagonists
|
EP0934932A4
(en)
*
|
1996-08-22 |
2002-06-26 |
Meiji Seika Kaisha |
CHINOLINE DERIVATIVES AND PSYCHOTROPES MEDIUM
|
FR2752732B1
(fr)
|
1996-08-28 |
1998-11-20 |
Pf Medicament |
Forme galenique a liberation prolongee de milnacipran
|
US6133253A
(en)
*
|
1996-12-10 |
2000-10-17 |
Abbott Laboratories |
3-Pyridyl enantiomers and their use as analgesics
|
US5962535A
(en)
*
|
1997-01-17 |
1999-10-05 |
Takeda Chemical Industries, Ltd. |
Composition for alzheimer's disease
|
DE19707655A1
(de)
*
|
1997-02-26 |
1998-08-27 |
Hoechst Ag |
Kombinationspräparat zur Anwendung bei Demenz
|
AU743609B2
(en)
*
|
1997-03-03 |
2002-01-31 |
Eisai Co. Ltd. |
Use of cholinesterase inhibitors to treat disorders of attention
|
WO1998056380A1
(en)
*
|
1997-06-11 |
1998-12-17 |
Alcon Laboratories, Inc. |
Method to reverse mydriasis
|
US6028083A
(en)
*
|
1997-07-25 |
2000-02-22 |
Hoechst Marion Roussel, Inc. |
Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
|
US5945421A
(en)
*
|
1997-08-11 |
1999-08-31 |
Warner-Lambert Company |
Dopamine D4 receptor antagonists
|
US6339087B1
(en)
|
1997-08-18 |
2002-01-15 |
Syntex (U.S.A.) Llc |
Cyclic amine derivatives-CCR-3 receptor antagonists
|
IL125658A0
(en)
|
1997-08-18 |
1999-04-11 |
Hoffmann La Roche |
Ccr-3 receptor antagonists
|
AU9454098A
(en)
|
1997-09-24 |
1999-04-12 |
Nova Molecular, Inc. |
Methods for increasing apoe levels for the treatment of neurodegenerative disease
|
DK1048653T3
(da)
*
|
1997-12-05 |
2004-05-24 |
Eisai Co Ltd |
Donepezilpolykrystaller og fremgangsmåde til fremstilling deraf
|
WO1999036405A1
(en)
|
1998-01-16 |
1999-07-22 |
Eisai Co., Ltd. |
Process for production of donepezil derivative
|
US6713627B2
(en)
|
1998-03-13 |
2004-03-30 |
Aventis Pharmaceuticals Inc. |
Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
|
US6066636A
(en)
|
1998-06-30 |
2000-05-23 |
Schering Corporation |
Muscarinic antagonists
|
US6262081B1
(en)
|
1998-07-10 |
2001-07-17 |
Dupont Pharmaceuticals Company |
Composition for and method of treating neurological disorders
|
US6218383B1
(en)
|
1998-08-07 |
2001-04-17 |
Targacept, Inc. |
Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
|
IL125809A
(en)
*
|
1998-08-17 |
2005-08-31 |
Finetech Lab Ltd |
Process and intermediates for production of donepezil and related compounds
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
CN1535682A
(zh)
*
|
1998-09-30 |
2004-10-13 |
����ҩƷ��ҵ��ʽ���� |
改善膀胱***能力的药物
|
US20020177593A1
(en)
|
1998-09-30 |
2002-11-28 |
Yuji Ishihara |
Agents and crystals for improving excretory potency of urinary bladder
|
BR9915520A
(pt)
*
|
1998-11-20 |
2001-07-17 |
Hoffmann La Roche |
Antagonistas receptores ccr-3 derivados de pirrolidina
|
KR20010081034A
(ko)
|
1998-11-20 |
2001-08-25 |
프리돌린 클라우스너, 롤란드 비. 보레르 |
피페리딘 씨씨알-3 수용체 길항제
|
CA2355296A1
(en)
*
|
1998-12-11 |
2000-06-15 |
American Biogenetic Sciences, Inc. |
Substituted nitrogen heterocyclic compounds and therapeutic uses thereof
|
US6277866B1
(en)
*
|
1999-03-03 |
2001-08-21 |
Eisai Co., Ltd. |
1-benzyl-4[(5,6-dimethoxy-2-fluoro-1-indanon)-2-yl]methylpiperidine
|
ATE277011T1
(de)
|
1999-03-03 |
2004-10-15 |
Eisai Co Ltd |
Flouride von 4-substituierten piperidin-derivaten
|
US6833370B1
(en)
|
1999-05-21 |
2004-12-21 |
Abbott Laboratories |
Heterocycle substituted aminoazacycles useful as central nervous system agents
|
GB9914486D0
(en)
|
1999-06-21 |
1999-08-18 |
Smithkline Beecham Plc |
Medicaments
|
GB9917406D0
(en)
|
1999-07-23 |
1999-09-22 |
Smithkline Beecham Plc |
Compounds
|
PT1209151E
(pt)
|
1999-09-01 |
2007-05-31 |
Eisai R&D Man Co Ltd |
Derivados piperidina 4-substituídos.
|
GB0002100D0
(en)
|
2000-01-28 |
2000-03-22 |
Novartis Ag |
Organic compounds
|
US20030153598A1
(en)
*
|
2000-07-25 |
2003-08-14 |
Raymond Pratt |
Methods for treating Parkinson's disease with cholinesterase inhibitors
|
EP1764101A1
(en)
*
|
2000-03-03 |
2007-03-21 |
Eisai R&D Management Co., Ltd. |
Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments
|
PT1311272E
(pt)
|
2000-03-03 |
2007-02-28 |
Eisai R&D Man Co Ltd |
Novos métodos utilizando inibidores de colinesterase
|
US20060183776A9
(en)
*
|
2000-03-03 |
2006-08-17 |
Eisai Co., Ltd. |
Liquid dosage formulations of donepezil
|
JP2003530437A
(ja)
*
|
2000-04-13 |
2003-10-14 |
マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ |
Aβ42低下物質
|
WO2001078728A1
(fr)
*
|
2000-04-13 |
2001-10-25 |
Eisai Co., Ltd. |
Inhibiteurs d'acetylcholinesterases contenant des sels de 1-benzyl-pyridinium
|
WO2001098271A1
(fr)
|
2000-06-21 |
2001-12-27 |
Eisai Co., Ltd. |
Compose piperidine 4-substitue
|
AU2001267899A1
(en)
*
|
2000-07-03 |
2002-01-14 |
Eisai Co. Ltd. |
Pharmaceutical compositions for controlling intraocular pressure
|
CN1317276C
(zh)
*
|
2000-09-29 |
2007-05-23 |
中国科学院上海药物研究所 |
一类吲哚基哌啶类化合物及其制备方法和用途
|
US20040029894A1
(en)
*
|
2000-12-07 |
2004-02-12 |
Nobuya Matsuoka |
Nootropic effect enhancer
|
JP2005511478A
(ja)
*
|
2001-04-03 |
2005-04-28 |
メルク エンド カムパニー インコーポレーテッド |
N−置換非アリール複素環アミジル系nmda/nr2b拮抗薬
|
WO2002096415A2
(en)
*
|
2001-05-25 |
2002-12-05 |
Schering Corporation |
Use of azetidinone substituted derivatives in the treatment of alzheimer's disease
|
CA2459146A1
(en)
*
|
2001-08-30 |
2003-03-13 |
Ortho-Mcneil Pharmaceutical, Inc. |
Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors
|
WO2003024450A1
(en)
*
|
2001-09-20 |
2003-03-27 |
Eisai Co., Ltd. |
Methods for treating prion diseases
|
US20050233003A1
(en)
*
|
2001-09-28 |
2005-10-20 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
|
US20050191359A1
(en)
*
|
2001-09-28 |
2005-09-01 |
Solubest Ltd. |
Water soluble nanoparticles and method for their production
|
US20050226934A1
(en)
*
|
2001-09-28 |
2005-10-13 |
Solubest Ltd. |
Inclusion complexes of active compounds in acrylate (co)polymers and methods for their production
|
US20050227911A1
(en)
*
|
2001-09-28 |
2005-10-13 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
|
US20050249786A1
(en)
*
|
2001-09-28 |
2005-11-10 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
|
WO2003032914A2
(en)
*
|
2001-10-17 |
2003-04-24 |
Eisai Co., Ltd. |
Methods for treating substance abuse with cholinesterase inhibitors
|
GB0126378D0
(en)
*
|
2001-11-02 |
2002-01-02 |
Oxford Biomedica Ltd |
Antigen
|
JPWO2003061658A1
(ja)
*
|
2002-01-22 |
2005-05-19 |
エーザイ株式会社 |
インダノン誘導体を含有するシグマ受容体結合剤
|
CN100340293C
(zh)
*
|
2002-02-07 |
2007-10-03 |
卫材R&D管理有限公司 |
毛发生长促进剂、适于经皮给药的制剂
|
CA2479249A1
(en)
*
|
2002-03-15 |
2003-09-25 |
Samaritan Pharmaceuticals, Inc. |
Neuroprotective spirostenol pharmaceutical compositions
|
JP4405811B2
(ja)
*
|
2002-03-29 |
2010-01-27 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
(1−インダノン)−(1,2,3,6−テトラヒドロピリジン)誘導体
|
US7652039B2
(en)
|
2002-05-17 |
2010-01-26 |
Sequella, Inc. |
Methods of use and compositions for the diagnosis and treatment of infectious disease
|
US20040033986A1
(en)
|
2002-05-17 |
2004-02-19 |
Protopopova Marina Nikolaevna |
Anti tubercular drug: compositions and methods
|
IL165589A
(en)
|
2002-06-14 |
2012-04-30 |
Toyama Chemical Co Ltd |
Pharmaceutical preparation to improve brain function and use
|
IL150509A
(en)
*
|
2002-07-01 |
2007-07-04 |
Joseph Kaspi |
Pharmaceutical preparations containing donafazil hydrochloride
|
EP1601666A2
(en)
*
|
2002-07-02 |
2005-12-07 |
Schering Corporation |
New neuropeptide y y5 receptor antagonists
|
US7148354B2
(en)
*
|
2002-07-24 |
2006-12-12 |
Dr. Reddy's Laboratories Limited |
Process for preparation of donepezil
|
IL150982A
(en)
|
2002-07-30 |
2007-02-11 |
Ori Lerman |
Process for making Donafzil
|
GB0218326D0
(en)
*
|
2002-08-07 |
2002-09-11 |
Glaxo Group Ltd |
Compounds
|
UA83645C2
(ru)
*
|
2002-10-24 |
2008-08-11 |
Мерц Фарма Гмбх Унд Ко. Кгаа |
Фармацевтический продукт, который содержит производное 1-аминоциклогексана и ингибитор ацетилхолинестеразы, его применение
|
US20060014801A1
(en)
*
|
2002-11-22 |
2006-01-19 |
The Johns Hopkins University |
Prevention and treatment of cognitive impairment using (R)-(-)-5-methyl-1-nicotynoyl-2-pyrazoline (MNP) and analogs
|
JP2004189706A
(ja)
*
|
2002-12-13 |
2004-07-08 |
Eisai Co Ltd |
高度アルツハイマー型痴呆治療剤
|
WO2004071431A2
(en)
*
|
2003-02-05 |
2004-08-26 |
Myriad Genetics, Inc. |
Method and composition for treating neurodegenerative disorders
|
US20080057491A1
(en)
*
|
2003-02-07 |
2008-03-06 |
Mckee Patrick A |
Substrates and inhibitors of antiplasmin cleaving enzyme and methods of use
|
US6649765B1
(en)
|
2003-02-12 |
2003-11-18 |
Usv Limited, Bsd Marg. |
Process for the preparation of 1-benzyl-4(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCL)
|
US6953856B2
(en)
*
|
2003-02-12 |
2005-10-11 |
Usv, Limited |
Process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCI)
|
US7186842B2
(en)
*
|
2003-02-12 |
2007-03-06 |
Usv, Ltd. |
Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof
|
US7439365B2
(en)
*
|
2003-11-17 |
2008-10-21 |
Usv, Ltd. |
Pharmaceutical salt of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine (Donepezil)
|
US20050288330A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Avinash Naidu |
Process for producing a polymorphic form of (1-Benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride)
|
US7521481B2
(en)
*
|
2003-02-27 |
2009-04-21 |
Mclaurin Joanne |
Methods of preventing, treating and diagnosing disorders of protein aggregation
|
CN100422148C
(zh)
*
|
2003-02-27 |
2008-10-01 |
天津药物研究院 |
工业化生产盐酸多奈哌齐的工艺方法
|
ATE487492T1
(de)
*
|
2003-02-27 |
2010-11-15 |
Eisai R&D Man Co Ltd |
Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit
|
US20060009433A1
(en)
*
|
2003-03-14 |
2006-01-12 |
Zhi-Xing Yao |
Neuroprotective spirostenol pharmaceutical compositions
|
EP1608371A1
(en)
*
|
2003-03-21 |
2005-12-28 |
Ranbaxy Laboratories, Ltd. |
Process for the preparation of donepezil and derivatives thereof
|
AU2003230195A1
(en)
*
|
2003-04-02 |
2004-10-25 |
Hetero Drugs Limited |
A novel process for amorphous form of donepezil hydrochloride
|
US20040229914A1
(en)
*
|
2003-04-02 |
2004-11-18 |
Dr. Reddy's Laboratories Limited |
Novel crystalline form-VI of donepezil hydrochloride and process for the preparation thereof
|
US7560560B2
(en)
|
2003-04-16 |
2009-07-14 |
Hetero Drugs Limited |
Crystalline forms of donepezil hydrochloride
|
WO2005003092A1
(en)
*
|
2003-07-01 |
2005-01-13 |
Hetero Drugs Limited |
Preparation of intermediates for acetyl cholinesterase inhibitors
|
CA2532207A1
(en)
*
|
2003-07-11 |
2005-07-21 |
Myriad Genetics, Inc. |
Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
|
GB0316915D0
(en)
|
2003-07-18 |
2003-08-20 |
Glaxo Group Ltd |
Compounds
|
RU2357734C2
(ru)
*
|
2003-07-25 |
2009-06-10 |
Ф.Хоффманн-Ля Рош Аг |
КОМБИНАЦИЯ АНТАГОНИСТА РЕЦЕПТОРА mGluR2 И ИНГИБИТОРА ФЕРМЕНТА AChE ДЛЯ ЛЕЧЕНИЯ ОСТРЫХ И/ИЛИ ХРОНИЧЕСКИХ НЕВРОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ
|
CN1280273C
(zh)
|
2003-11-05 |
2006-10-18 |
天津和美生物技术有限公司 |
合成多奈哌齐及其衍生物的方法
|
DK1689721T3
(da)
*
|
2003-11-26 |
2010-09-20 |
Pfizer Prod Inc |
Aminopyrazolderivater som GSK-3-ihibitorer
|
CA2552221A1
(en)
*
|
2003-12-31 |
2005-07-21 |
Actavis Group Hf |
Donepezil formulations
|
CN1300112C
(zh)
*
|
2004-01-06 |
2007-02-14 |
浙江大学 |
N-苄基-4-哌啶基甲醛的合成方法
|
US20050222123A1
(en)
|
2004-01-27 |
2005-10-06 |
North Shore-Long Island Jewish Research Institute |
Cholinesterase inhibitors for treating inflammation
|
MY142362A
(en)
*
|
2004-01-29 |
2010-11-30 |
Otsuka Pharma Co Ltd |
Pharmaceutical composition for promoting angiogenesis
|
EP1729761A4
(en)
*
|
2004-03-05 |
2008-09-03 |
Eisai Co Ltd |
TREATMENT OF CADASIL WITH CHOLINESTERASE INHIBITORS
|
WO2006001877A2
(en)
*
|
2004-04-13 |
2006-01-05 |
Myriad Genetics, Inc. |
Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
|
WO2005105742A1
(ja)
*
|
2004-04-28 |
2005-11-10 |
Eisai R&D Management Co., Ltd. |
1-ベンジル-4-[(5,6-ジメトキシ-1-インダノン)-2-イル]メチルピペリジンおよびその塩酸塩の製造法
|
WO2005108683A1
(en)
*
|
2004-04-29 |
2005-11-17 |
Keystone Retaining Wall Systems, Inc. |
Veneers for walls, retaining walls and the like
|
WO2005112908A1
(en)
*
|
2004-05-14 |
2005-12-01 |
The Johns Hopkins University |
Method for improving cognitive function
|
EP1779867A4
(en)
|
2004-07-01 |
2009-12-02 |
Eisai R&D Man Co Ltd |
MEANS FOR PROMOTING NERVE REVENERATION
|
EP1773339A4
(en)
*
|
2004-07-30 |
2009-07-29 |
Reddys Lab Ltd Dr |
CRYSTALLINE FORM OF DONEPEZIL HYDROCHLORIDE
|
WO2006020853A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
WO2006020850A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
WO2006020852A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
HUP0401850A3
(en)
*
|
2004-09-15 |
2008-03-28 |
Egis Gyogyszergyar Nyilvanosan |
Donepezil salts for producing pharmaceutical composition
|
US7718674B2
(en)
|
2004-09-27 |
2010-05-18 |
Bridge Pharma, Inc. |
Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
|
WO2006035433A2
(en)
*
|
2004-09-29 |
2006-04-06 |
Chemagis Ltd. |
Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride
|
GB2419093A
(en)
*
|
2004-10-12 |
2006-04-19 |
Ernir Snorrason |
Acetylcholinesterase inhibitors for the treatment of skin
|
EP1807087A2
(en)
*
|
2004-10-12 |
2007-07-18 |
Ernir Snorrason |
Inhibitors of acetylcholinesterase for treating skin diseases
|
EP1812007B1
(en)
*
|
2004-11-02 |
2011-09-07 |
Northwestern University |
Pyridazine compounds and methods
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
EP1819681B1
(en)
*
|
2004-11-23 |
2009-08-12 |
Warner-Lambert Company LLC |
7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
|
US20060122226A1
(en)
|
2004-12-08 |
2006-06-08 |
Itai Adin |
Crystalline forms of Donepezil base
|
CA2591894C
(en)
*
|
2004-12-30 |
2013-08-20 |
Jubilant Organosys Limited |
Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon2-yl)methyl] piperidine or its salt thereof via novel intermediate
|
WO2006086698A2
(en)
|
2005-02-11 |
2006-08-17 |
Stephen Wills |
Treating microvasculature diseases with acetyl cholinesterase inhibitors
|
EP1858848A1
(en)
*
|
2005-03-17 |
2007-11-28 |
Synthon B.V. |
Process for making crystalline donepezil hydrochloride monohydrate
|
AU2006232517A1
(en)
*
|
2005-04-04 |
2006-10-12 |
Eisai R&D Management Co., Ltd. |
Dihydropyridine compounds and compositions for headaches
|
CA2604052C
(en)
|
2005-04-06 |
2014-07-08 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for the treatment of cns-related conditions
|
US20080188510A1
(en)
*
|
2005-05-23 |
2008-08-07 |
Eisai R & D Management Co., Ltd. |
Novel methods using zonisamide
|
US20070015832A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Myriad Genetics, Incorporated |
Methods of treating overactive bladder and urinary incontinence
|
WO2007010910A1
(en)
*
|
2005-07-15 |
2007-01-25 |
Eisai R & D Management Co., Ltd. |
1-benzyl-4-[(5, 6-dimethoxy-1-indanon)-2-yl]-methyl piperidine p-toluenesulfonate or crystal thereof
|
NZ564789A
(en)
*
|
2005-07-22 |
2010-07-30 |
Myriad Genetics Inc |
High drug load formulations and dosage forms
|
CA2616117A1
(en)
*
|
2005-07-25 |
2007-02-01 |
Eisai R&D Management Co., Ltd. |
Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-ylidene]methylpiperidine
|
JP2009502917A
(ja)
*
|
2005-07-28 |
2009-01-29 |
テイコク ファーマ ユーエスエー インコーポレーテッド |
ゲル化ドネペジル組成物および該組成物の製法並びに使用法
|
CN100436416C
(zh)
*
|
2005-07-29 |
2008-11-26 |
西南合成制药股份有限公司 |
盐酸多奈哌齐合成工艺
|
GB0515803D0
(en)
|
2005-07-30 |
2005-09-07 |
Pliva Hrvatska D O O |
Intermediate compounds
|
CN101263117B
(zh)
*
|
2005-10-14 |
2012-05-23 |
卫材R&D管理有限公司 |
制备1-苄基-4-[(5,6-二甲氧基-1-二氢茚酮)-2-基]甲基哌啶或其盐酸盐的方法
|
AU2006300492B2
(en)
*
|
2005-10-14 |
2011-08-25 |
Eisai R & D Management Co., Ltd. |
Process for producing 1-benzyl-4-[(5,6-dimethoxy-1indanon)-2-yl]methylpiperidine or hydrochloride thereof
|
US8173642B2
(en)
|
2005-10-25 |
2012-05-08 |
Shionogi & Co., Ltd. |
Aminodihydrothiazine derivatives
|
JP2008280248A
(ja)
*
|
2005-11-02 |
2008-11-20 |
Eisai R & D Management Co Ltd |
アルツハイマー型痴呆症治療薬塩酸ドネペジルのプロドラッグ
|
AR057910A1
(es)
|
2005-11-18 |
2007-12-26 |
Synthon Bv |
Proceso para preparar donepezilo
|
HU227474B1
(en)
*
|
2005-12-20 |
2011-07-28 |
Richter Gedeon Nyrt |
Process for industrial scale production of high purity donepezil hydrochloride polymorph i.
|
KR20080085195A
(ko)
*
|
2006-01-04 |
2008-09-23 |
씨아이피엘에이 엘티디. |
도네페질의 제조방법 및 중간체
|
US7994328B2
(en)
|
2006-02-16 |
2011-08-09 |
Aurobindo Pharma Ltd. |
Process for the preparation of donepezil hydrochloride
|
JPWO2007099828A1
(ja)
|
2006-02-23 |
2009-07-16 |
塩野義製薬株式会社 |
環式基で置換された含窒素複素環誘導体
|
US20100113793A1
(en)
*
|
2006-03-20 |
2010-05-06 |
Ind-Swift Laboratories Limited |
Process for the Preparation of Highly Pure Donepezil
|
US8158627B2
(en)
*
|
2006-04-28 |
2012-04-17 |
Northwestern University |
Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
|
EP2026766A1
(en)
|
2006-05-17 |
2009-02-25 |
Synthon B.V. |
Tablet composition with a prolonged release of tamsulosin
|
US8933201B2
(en)
|
2006-06-07 |
2015-01-13 |
The Board Of Regents Of The University Of Oklahoma |
Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use
|
EP2046119A2
(en)
*
|
2006-07-07 |
2009-04-15 |
Myriad Genetics, Inc. |
Treatment of psychiatric disorders
|
CL2007002070A1
(es)
|
2006-07-14 |
2008-02-08 |
Ac Immune S A Genentech Inc |
Anticuerpo quimerico o humanizado, o fragmentos de ellos, que se adhieren especificamente a por lo menos un epitopo en la proteina beta-amiloide; molecula de acido nucleico que lo codifica; composicion que lo comprende; su uso para tratar enfermedade
|
WO2008010235A2
(en)
*
|
2006-07-19 |
2008-01-24 |
Torrent Pharmaceuticals Limited |
An improved process for the preparation of donepezil
|
WO2008011161A2
(en)
|
2006-07-21 |
2008-01-24 |
Bridge Pharma, Inc. |
Dermal anesthetic compounds
|
WO2008019431A1
(en)
*
|
2006-08-14 |
2008-02-21 |
Brc Operations Pty Limited |
Method and compositions for simultaneously regulating memory and mood
|
WO2008033466A2
(en)
*
|
2006-09-14 |
2008-03-20 |
Combinatorx (Singapore) Pre. Ltd. |
Compositions and methods for treatment of viral diseases
|
WO2008051599A2
(en)
|
2006-10-27 |
2008-05-02 |
Medivation Neurology, Inc. |
Combination therapies for treating alzheimer's disease using i. a. dimebon and dolepezil
|
RU2478619C2
(ru)
|
2006-12-11 |
2013-04-10 |
Ривайва Фармасьютикалс, Инк. |
Композиции, синтез и способы применения ингибиторов холинэстеразы на основе инданона
|
JP2010520154A
(ja)
*
|
2007-03-05 |
2010-06-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
神経変性疾患のためのampaレセプターアンタゴニストおよびnmdaレセプターアンタゴニスト
|
KR20080092515A
(ko)
*
|
2007-04-12 |
2008-10-16 |
동화약품공업주식회사 |
도네페질 중간체의 제조방법
|
AU2008245082B8
(en)
|
2007-04-24 |
2012-09-13 |
Shionogi & Co., Ltd. |
Aminodihydrothiazine derivatives substituted with a cyclic group
|
JP5383483B2
(ja)
*
|
2007-04-24 |
2014-01-08 |
塩野義製薬株式会社 |
アルツハイマー症治療用医薬組成物
|
WO2008139984A1
(en)
*
|
2007-04-26 |
2008-11-20 |
Eisai R & D Management Co., Ltd. |
Cinnamide compounds for dementia
|
MX2009012117A
(es)
*
|
2007-05-09 |
2009-11-23 |
Pfizer |
Composiciones y derivados heterociclicos sustituidos y su uso farmaceutico como antibacterianos.
|
RU2469723C2
(ru)
|
2007-05-22 |
2012-12-20 |
Оцука Фармасьютикал Ко., Лтд. |
Лекарственное средство, содержащее производное карбостирила и донепезил, для лечения болезни альцгеймера
|
US8048420B2
(en)
|
2007-06-12 |
2011-11-01 |
Ac Immune S.A. |
Monoclonal antibody
|
BRPI0812478A2
(pt)
*
|
2007-06-12 |
2017-05-16 |
Ac Immune Sa |
anticorpo quimérico ou um fragmento do mesmo, ou anticorpo humanizado ou um fragmento do mesmo, molécula de ácido nucleico, vetor de expressão, célula, composição, métodos de prevenir, tratar ou aliviar os efeitos d euma ou mais doenças, de diagnosticar uma doença ou condição associada com amilóide em um indivíduo, de determinar a extensão de carga de placa amiloidogênica em um tecido e/ou fluidos corporais de um indivíduo, de desagregar fibras beta-amilóides pré-formadas e de prevenir degradação de neurônios induzidas por abeta, kit de teste, região variável de cadeia, e, linhagem de célula
|
US8613923B2
(en)
|
2007-06-12 |
2013-12-24 |
Ac Immune S.A. |
Monoclonal antibody
|
CA2690110A1
(en)
*
|
2007-07-13 |
2009-01-22 |
Eisai R&D Management Co., Ltd. |
Ampa receptor antagonists for neuropathic pain
|
DE102007037932A1
(de)
|
2007-08-11 |
2009-02-12 |
Alfred E. Tiefenbacher Gmbh & Co.Kg |
Donepezilhydrochlorid in amorpher Form enthaltende Tablette
|
US8304435B2
(en)
|
2007-09-12 |
2012-11-06 |
Deuteria Pharmaceuticals Inc. |
Deuterium-enriched donepezil
|
JP5426554B2
(ja)
*
|
2007-09-28 |
2014-02-26 |
天津和美生物技▲術▼有限公司 |
ドネペジル塩、その多形体、その製造方法、応用方法および組成物
|
TWI432195B
(zh)
|
2007-10-03 |
2014-04-01 |
Kowa Co |
神經細胞死亡抑制劑
|
AU2008311367B2
(en)
*
|
2007-10-05 |
2014-11-13 |
Ac Immune S.A. |
Use of anti-amyloid beta antibody in ocular diseases
|
CN101998863B
(zh)
*
|
2007-10-05 |
2015-09-16 |
基因技术公司 |
抗淀粉状蛋白β抗体在眼病中的用途
|
JP5566004B2
(ja)
|
2007-11-14 |
2014-08-06 |
株式会社Dnpファインケミカル宇都宮 |
アルコキシインダノン誘導体の製造方法
|
WO2009118516A1
(en)
|
2008-03-25 |
2009-10-01 |
Cipla Limited |
Process for the preparation of donepezil hydrochloride
|
EP2291181B9
(en)
|
2008-04-18 |
2013-09-11 |
University College Dublin National University Of Ireland, Dublin |
Captodiamine for the treatment of depression symptoms
|
WO2009128058A1
(en)
|
2008-04-18 |
2009-10-22 |
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al |
Psycho-pharmaceuticals
|
US20090291127A1
(en)
*
|
2008-05-21 |
2009-11-26 |
Jianye Wen |
Transdermal anti-dementia active agent formulations and methods for using the same
|
NZ589590A
(en)
*
|
2008-06-13 |
2012-05-25 |
Shionogi & Co |
Sulfur-containing heterocyclic derivative having beta-secretase-inhibiting activity
|
WO2010019560A1
(en)
*
|
2008-08-12 |
2010-02-18 |
Concert Pharmaceuticals Inc. |
Deuterated derivatives of donepezil
|
JP2012504163A
(ja)
*
|
2008-09-30 |
2012-02-16 |
テイコク ファーマ ユーエスエー インコーポレーテッド |
経皮持続送達ドネペジル組成物および該組成物を使用する方法
|
EP2360155A4
(en)
*
|
2008-10-22 |
2012-06-20 |
Shionogi & Co |
2-AMINOPYRIDIN-4-ON AND 2-AMINOPYRIDINE DERIVATIVE WITH BACE1-HEMDERING EFFECT
|
US20100105916A1
(en)
*
|
2008-10-29 |
2010-04-29 |
Sterling Biotech Limited |
Processes for Preparing Donepezil
|
WO2010053861A2
(en)
*
|
2008-11-07 |
2010-05-14 |
H. Lundbeck A/S |
Biologically active amides
|
WO2010077730A2
(en)
*
|
2008-12-09 |
2010-07-08 |
Auspex Pharmaceutical, Inc |
Indanone inhibitors of acetylcholinesterase
|
US8247405B2
(en)
|
2008-12-10 |
2012-08-21 |
Conopco, Inc. |
Skin lightening compositions with acetylcholinesterase inhibitors
|
JP5562337B2
(ja)
|
2008-12-17 |
2014-07-30 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ドネペジルの多形結晶及びその製造方法
|
US8465770B2
(en)
*
|
2008-12-24 |
2013-06-18 |
Synthon Bv |
Low dose controlled release tablet
|
EP2674150A1
(de)
|
2009-01-28 |
2013-12-18 |
Labtec GmbH |
Pharmazeutische Zubereitung mit verbesserter Stabilität des Wirkstoffs
|
WO2011004705A1
(ja)
*
|
2009-07-10 |
2011-01-13 |
ユニマテック株式会社 |
ポリフルオロアルキルホスホン酸エステルおよびその製造法
|
JP4666093B2
(ja)
*
|
2009-03-13 |
2011-04-06 |
ユニマテック株式会社 |
ポリフルオロアルキルホスホン酸エステルの製造法
|
WO2011055609A1
(ja)
*
|
2009-11-04 |
2011-05-12 |
ユニマテック株式会社 |
ポリフルオロアルキルホスホン酸塩乳化剤およびこれを有効成分とする離型剤
|
HUE033352T2
(en)
|
2009-11-18 |
2017-11-28 |
Suven Life Sciences Ltd |
Bicyclic compounds as alpha4-beta2 nicotinic acetylcholine receptor ligands
|
WO2011061591A1
(en)
|
2009-11-18 |
2011-05-26 |
Jubilant Life Sciences Limited |
Improved process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanone)-2-yl)methyl piperidine hydrochloride form-iii
|
MX2012006491A
(es)
|
2009-12-11 |
2012-07-03 |
Shionogi & Co |
Derivados de oxazina.
|
ES2552932T3
(es)
|
2009-12-29 |
2015-12-03 |
Suven Life Sciences Limited |
Ligandos del receptor nicotínico neuronal de la acetilcolina alfa4beta2
|
US20100178307A1
(en)
*
|
2010-01-13 |
2010-07-15 |
Jianye Wen |
Transdermal anti-dementia active agent formulations and methods for using the same
|
JP6082250B2
(ja)
|
2010-02-09 |
2017-02-15 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
認知機能を改善するための方法および組成物
|
WO2011127235A1
(en)
|
2010-04-07 |
2011-10-13 |
Eisai Inc. |
Combination therapy for the treatment of dementia
|
GR1007368B
(el)
|
2010-05-27 |
2011-08-02 |
Alapis Α.Β.Ε.Ε., |
Ποσιμα φαρμακευτικα διαλυματα για τη θεραπεια των συμπτωματων της ανοιας
|
WO2011151359A1
(en)
|
2010-06-02 |
2011-12-08 |
Noscira, S.A. |
Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
|
FR2962335B1
(fr)
|
2010-07-12 |
2013-01-18 |
Cll Pharma |
Utilisation du nonapeptide pat dans le traitement et la prevention des maladies neurodegeneratives
|
WO2012016173A2
(en)
|
2010-07-30 |
2012-02-02 |
Ac Immune S.A. |
Safe and functional humanized antibodies
|
TR201007110A2
(tr)
|
2010-08-25 |
2012-03-21 |
Bi̇lgi̇ç Mahmut |
Sinerjik etki gösteren kombinasyonlar
|
TR201007109A2
(tr)
|
2010-08-25 |
2012-03-21 |
Bi̇lgi̇ç Mahmut |
Tek birim dozaj formları.
|
WO2012038966A1
(en)
|
2010-09-22 |
2012-03-29 |
Tyche Industries Ltd. |
Process for the preparation of donepezil intermediate
|
WO2012057247A1
(ja)
|
2010-10-29 |
2012-05-03 |
塩野義製薬株式会社 |
縮合アミノジヒドロピリミジン誘導体
|
WO2012057248A1
(ja)
|
2010-10-29 |
2012-05-03 |
塩野義製薬株式会社 |
ナフチリジン誘導体
|
US9145372B2
(en)
|
2010-11-15 |
2015-09-29 |
Agenebio, Inc. |
Pyridazine derivatives, compositions and methods for treating cognitive impairment
|
WO2012071369A2
(en)
|
2010-11-24 |
2012-05-31 |
The Trustees Of Columbia University In The City Of New York |
A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
|
CN103608345A
(zh)
|
2011-04-26 |
2014-02-26 |
盐野义制药株式会社 |
噁嗪衍生物和含有该噁嗪衍生物的bace1抑制剂
|
DE202012013538U1
(de)
|
2011-05-16 |
2017-08-07 |
Weitzer Holding Gmbh |
Boden- und Wandbelagsystem mit schalldämpfenden Verlegeeinheiten
|
EP2565186A1
(en)
*
|
2011-09-02 |
2013-03-06 |
Hybrigenics S.A. |
Selective and reversible inhibitors of ubiquitin specific protease 7
|
MX2014012374A
(es)
|
2012-04-14 |
2015-04-17 |
Intra Cellular Therapies Inc |
Compuestos organicos.
|
CN103524515B
(zh)
|
2012-07-03 |
2016-07-06 |
浙江海正药业股份有限公司 |
具有乙酰胆碱酯酶抑制活性的苯并间二氧杂环戊烯衍生物及其制备方法和用途
|
WO2014065434A1
(en)
|
2012-10-24 |
2014-05-01 |
Shionogi & Co., Ltd. |
Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity
|
CN103787954B
(zh)
|
2012-10-26 |
2016-01-20 |
中国科学院上海药物研究所 |
一类氟取代的环状胺类化合物及其制备方法、药物组合物和用途
|
WO2014078568A1
(en)
|
2012-11-14 |
2014-05-22 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
WO2014076965A1
(ja)
*
|
2012-11-16 |
2014-05-22 |
学校法人北里研究所 |
抗原虫活性を示す1-インダン誘導体
|
EP2759536A1
(en)
|
2013-01-25 |
2014-07-30 |
INSA (Institut National des Sciences Appliquees) de Rouen |
Oxidisable pyridine derivatives, their preparation and use as anti-Alzheimer agents
|
WO2014144663A1
(en)
|
2013-03-15 |
2014-09-18 |
The Johns Hopkins University |
Methods and compositions for improving cognitive function
|
EP2968220B1
(en)
|
2013-03-15 |
2021-05-05 |
Agenebio, Inc. |
Methods and compositions for improving cognitive function
|
JP6319912B2
(ja)
|
2013-04-19 |
2018-05-09 |
国立大学法人 岡山大学 |
アミロイドβ蛋白質により誘発される認知障害の治療剤およびアルツハイマー病治療薬、ならびにこれらに関連する治療方法および病態解析方法
|
EP3033082B1
(en)
|
2013-08-16 |
2021-06-16 |
Universiteit Maastricht |
Treatment of cognitive impairment with pde4 inhibitor
|
US9359315B2
(en)
|
2013-09-10 |
2016-06-07 |
Arrien Pharmaceuticals Llc |
Substituted 2,3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis
|
CA3123897C
(en)
|
2013-12-20 |
2024-02-06 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
FR3018689B1
(fr)
*
|
2014-03-20 |
2017-04-28 |
Centre Hospitalier Univ De Clermont Ferrand |
Inhibiteurs de l'acetylcholinesterase d'action centrale pour la prevention et/ou le traitement des neuropathies chimio-induites et leurs symptomes, compositions, utilisations, methodes et trousse correspondantes.
|
CN105753768B
(zh)
*
|
2014-12-15 |
2020-11-27 |
北京恒瑞新霖科技有限公司 |
一种含单个氮杂环化合物的生产方法
|
AR103297A1
(es)
|
2014-12-30 |
2017-05-03 |
Forma Therapeutics Inc |
Pirrolo y pirazolopirimidinas como inhibidores de la proteasa 7 específica de ubiquitina
|
MA41291A
(fr)
|
2014-12-30 |
2017-11-07 |
Forma Therapeutics Inc |
Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer
|
JP2018504431A
(ja)
|
2015-02-05 |
2018-02-15 |
フォーマ セラピューティクス,インコーポレイテッド |
ユビキチン特異的プロテアーゼ7阻害物質としてのチエノピリミジノン
|
JP2018504430A
(ja)
|
2015-02-05 |
2018-02-15 |
フォーマ セラピューティクス,インコーポレイテッド |
ユビキチン特異的プロテアーゼ7阻害物質としてのキナゾリノン及びアザキナゾリノン
|
EP3253759A1
(en)
|
2015-02-05 |
2017-12-13 |
Forma Therapeutics, Inc. |
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
|
CA2986598C
(en)
|
2015-05-22 |
2023-09-26 |
Agenebio, Inc. |
Extended release pharmaceutical compositions of levetiracetam
|
CA2990004C
(en)
|
2015-06-19 |
2024-04-23 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
CN115252586A
(zh)
|
2015-06-22 |
2022-11-01 |
考里安公司 |
包含难溶性治疗剂的透皮粘合剂组合物
|
CN105367483B
(zh)
*
|
2015-11-20 |
2017-12-26 |
山东淄博新达制药有限公司 |
盐酸多奈哌齐的制备方法
|
AU2017279027A1
(en)
|
2016-06-08 |
2018-12-20 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical Compounds
|
CN109922796B
(zh)
|
2016-06-23 |
2023-04-07 |
考里安有限责任公司 |
具有亲水和疏水域的粘合剂基质和治疗剂
|
WO2018016714A1
(ko)
|
2016-07-20 |
2018-01-25 |
주식회사 엔솔바이오사이언스 |
신규 펩타이드 및 그 용도
|
US9993466B2
(en)
|
2016-07-27 |
2018-06-12 |
Corium International, Inc. |
Donepezil transdermal delivery system
|
WO2018022818A1
(en)
|
2016-07-27 |
2018-02-01 |
Corium International, Inc. |
Memantine transdermal delivery systems
|
WO2018022814A1
(en)
|
2016-07-27 |
2018-02-01 |
Corium International, Inc. |
Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
|
US20180170941A1
(en)
|
2016-12-19 |
2018-06-21 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
US11505555B2
(en)
|
2016-12-19 |
2022-11-22 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
US10369187B2
(en)
|
2017-02-09 |
2019-08-06 |
Vanderbilt University |
Peptide regulators of JNK family kinases
|
AU2018383672A1
(en)
|
2017-12-13 |
2020-07-02 |
Corium, LLC. |
Method for depot creation during transdermal drug delivery
|
CA3086163A1
(en)
|
2017-12-20 |
2019-06-27 |
Corium, Inc. |
Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
|
JP2021528427A
(ja)
|
2018-06-19 |
2021-10-21 |
エージンバイオ, インコーポレイテッド |
認知障害を処置するためのベンゾジアゼピン誘導体、組成物および方法
|
PT3843702T
(pt)
|
2019-05-31 |
2023-10-13 |
Tecnimede Soc Tecnico Medicinal Lda |
Combinação de dose fixa de libertação imediata de memantina e donepezilo
|
JP7452810B2
(ja)
*
|
2019-06-17 |
2024-03-19 |
東和薬品株式会社 |
固定化触媒を用いたフロー反応によるドネペジルの製造方法
|
KR20220059300A
(ko)
*
|
2020-11-02 |
2022-05-10 |
주식회사 종근당 |
인덴 유도체 프로드럭의 산부가염 및 이의 제조방법
|
KR102451185B1
(ko)
|
2021-08-05 |
2022-10-07 |
환인제약 주식회사 |
도네페질 함유 지속방출형 미립구
|
WO2024039886A1
(en)
|
2022-08-19 |
2024-02-22 |
Agenebio, Inc. |
Benzazepine derivatives, compositions, and methods for treating cognitive impairment
|